Foxchart.com
TransEnterix, Inc. (TRXC)
0.3265  0.003 (1.05%)  07-10 16:00
Open: 0.34
High: 0.3366
Low: 0.32
Volume: 5,029,368
Market Cap: 33(M)
PE Ratio: 0
Exchange: NYSE American
Industry: Medical Devices
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 1.03
Resistance 1: 0.76
Pivot price: 0.46
Support 1: 0.32
Support 2: 0.27
52w High: 19.109995
52w Low: 0.28
Watchlist
MSFT213.67-0.65 (-0.3%)
TWTR35.4-0.32 (-0.9%)
BAC24.021.25 (5.49%)
AMZN320017.37 (0.55%)
FB245.070.57 (0.23%)
GM24.390.97 (4.14%)
Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company's products include Senhance System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.

Financials
EPS -7.150
Book Value 1.430
PEG Ratio 0.00
Gross Profit -0.092
Profit Margin (%) 0.00
Operating Margin (%) -1133.60
Return on Assets (ttm) -32.7
Return on Equity (ttm) -138.6
×
Share on Facebook Tweet this page

Foxchart international:  |  United States  |  Canada  |  United Kingdom  |  Australia  |  New Zealand  |  Singapore  |  India

©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX